Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis

The World Health Organization recommends pre-exposure prophylaxis (PrEP) for individuals at substantial risk of HIV infection. The aim of this analysis is to quantify the individual risk of HIV infection over time, using a large database of high-risk individuals (n = 5583). We used data from placebo...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Cremades, Maria, Hendrix, Craig W., Jayachandran, Priya, Strydom, Natasha, Jarlsberg, Leah, Grant, Robert, Celum, Connie L., Martin, Michael, Baeten, Jared M., Marrazzo, Jeanne, Anderson, Peter, Choopanya, Kachit, Vanichseni, Suphak, Glidden, David V., Savic, Radojka M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504389/
https://www.ncbi.nlm.nih.gov/pubmed/36145549
http://dx.doi.org/10.3390/pharmaceutics14091801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504389/
https://www.ncbi.nlm.nih.gov/pubmed/36145549
http://dx.doi.org/10.3390/pharmaceutics14091801

Ejemplares similares